32 소아와 청소년의 2형 당뇨병 329

25. Libman IM, Barinas-Mitchell E, Bartucci A, et al. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008; 93:4231-7.
26. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
27. Reinehr T, Andler W, Kapellen T, et al. Clinical characteristics of type 2 diabetes mellitus in over-weight European Caucasian adolescents. Exp Clin Endocrinol Diabetes 2005;113:167-70.
28. Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adoles-cents with NIDDM. Diabetes Care 1997;20:484-6.
29. Sellers EA, Dean HJ. Diabetic ketoacidosis: a com-plication of type 2 diabetes in Canadian aboriginal youth. Diabetes Care 2000;23:1202-4.
30. Dabelea D, Palmer JP, Bennett PH, et al. Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus. Diabetolo-gia 1999;42:1265-6.
31. Sellers E, Eisenbarth G, Young TK, Dean HJ. Diabetes-associated autoantibodiesin aboriginal children. Lancet 2000;355:1156.
32. Hathout EH, Thomas W, El-Shahawy M, et al. Diabetic autoimmune markers in children and ado-lescents with type 2 diabetes. Pediatrics 2001;107: E102.
33. Ferrannini E. Insulin resistance versus insulin defi-ciency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998;19:477-90.
34. Sellers EA, Triggs-Raine B, Rockman-Greenberg C, Dean HJ. The prevalence of the HNF-1alpha G319S mutation in Canadian aboriginal youth with type 2 diabetes. Diabetes Care 2002;25:2202-6.
35. Hattersley AT. Molecular genetics goes to the dia-betes clinic. Clin Med 2005;5:476-81.
36. Pinhas-Hamiel O, Standiford D, Hamiel D, et al. The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med 1999;153:1063-7.
37. Johnson ST, Newton AS, Chopra M, et al. In search of quality evidence for lifestyle management and glycemic control in children and adolescents with type 2 diabetes: a systematic review. BMC Pediatr 2010;10:97.
38. TODAY Study Group; Wilfley D, Berkowitz R, Goebbel-Fabbri A, et al. Binge eating, mood, and quality of life in youth with type 2 diabetes: base-line data from the TODAY study. Diabetes Care 2011;34:858-60.
39. Sellers EA, Dean HJ. Short-term insulin therapy in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2004;17:1561-4.
40. Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 dia-betes: a randomized controlled trial. Diabetes Care 2002;25:89-94.
41. Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a random-ized, single-blind comparative study. Diabetes Care 2007;30:790-4.
42. TODAY Study Group, Zeitler P, Hirst K, et al. A clini-cal trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012;366:2247-56.
43. Malloy J, Capparelli E, Gottschalk M, et al. Pharma-cology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mel-litus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study. Clin Ther 2009;31:806-15.
44. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the advi-sory committee on immunization practices (ACIP). MMWR Recomm Rep 2000;49(RR-9):1-35.
45. Crighton EJ, Elliott SJ, Moineddin R, Kanaroglou P, Upshur R. A spatial analysis of the determinants of pneumonia and influenza hospitalizations in On-tario(1992-2001). Soc Sci Med 2007;64:1636-50.
46. Fanella ST, Pinto MA, Bridger NA, et al. Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave. Infect Control Hosp Epidemiol 2011;32:435-43.
47. Rosenbloom AL. Hyperglycemic hyperosmolar state: an emerging pediatric problem. J Pediatr 2010; 156:180-4.
48. Fourtner SH, Weinzimer SA, Levitt Katz LE. Hy-perglycemic hyperosmolar nonketotic syndrome in children with type 2 diabetes. Pediatr Diabetes 2005;6:129-35.
49. Carchman RM, Dechert-Zeger M, Calikoglu AS, Harris BD. A new challenge in pediatric obesity:
<PAGE>329